ҚАЗАҚСТАНДАҒЫ КРОН АУРУЫ: АУРУШАҢДЫҚТЫҢ ЭПИДЕМИОЛОГИЯЛЫҚ АСПЕКТІЛЕРІ

##article.authors##

  • Sauirbay B SAKHANOV «Астана медицина университеті»
  • Dulat K TUREBAEV «Астана медицина университеті» ҚеАҚ
  • Dariyana M KULMIRZAEVA «Ұлттық нейрохирургия орталығы» АҚ
  • Saltanat N URAZOVA «Астана медицина университеті» ҚеАҚ
  • Akmaral К AMANSHAYEVA Орталық Азия онкологиялық институты
  • Zarina A BILYALOVA Орталық Азия онкологиялық институты
  • Saken K KOZHAKHMETOV Орталық Азия онкологиялық институты
  • Nurbek S IGISSINOV Eurasian Institute for Cancer Research

##semicolon##

https://doi.org/10.31082/1728-452X-2020-221-222-11-12-22-26

##semicolon##

Крон ауруы##common.commaListSeparator## аурушаңдығы##common.commaListSeparator## тенденциялары##common.commaListSeparator## Қазақстан

##article.abstract##

Crohn's disease (CD) is a chronic inflammatory disease of the gastrointestinal tract with an increasing incidence worldwide and widespread in industrialized countries, while the incidence is also increasing in Asia and the Middle East.

Purpose of the study. To study the epidemiological aspects of the incidence of CD in Kazakhstan. Material and methods. The study for 2013-2018, analyzed the registration and reporting forms of the Ministry of Health of the Republic of Kazakhstan on new cases of CD (ICD: K50) using descriptive and analytical methods of biomedical statistics.

Results. During the study period, 4,671 new cases of CD were registered in Kazakhstan, of which 341 (7.9%) in children under 15 years old, 84 (2.0%) in adolescents (15-17 years old) and adults (18 years old and older) – 4,226 cases (90.9%). The incidence of CD in Kazakhstan was 4.5 per 100,000 of the total population, while in children – 1.210/0000 (95% CI=1.09-1.32), in adolescents – 2.120/0000 (95% CI=1.47-2.77) and the adult population – 5.860/0000 (95% CI=3.20-8.53). The trends in the CD incidence as a whole in the entire population had a pronounced tendency to decrease (Тde=−30.3%), a slight increase was observed only in the child population (Тin=+1.1%), and in other studied groups they decreased: in adolescents – Тde=−11.9% and in the adult population – Тde=−33.8%.

Conclusion. The study has revealed some aspects of incidence in different age groups and the established trends require further study of this pathology.

##submission.citations##

Molodecky NA, Soon IS, Rabi DM, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2012;142(1):46-e30. doi: 10.1053/j.gastro.2011.10.001.

Torres J, Mehandru S, Colombel JF, Peyrin-Biroulet L. Crohn's disease. Lancet. 2017;389(10080):1741-1755. doi: 10.1016/S0140- 6736(16)31711-1.

Aniwan S, Park SH, Loftus EV Jr. Epidemiology, Natural History, and Risk Stratification of Crohn's Disease. Gastroenterol Clin North Am. 2017;46(3):463-480. doi: 10.1016/j.gtc.2017.05.003.

Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol. 2015;12(4):205-217. doi: 10.1038/nrgastro.2015.34.

Dahlhamer JM, Zammitti EP, Ward BW, Wheaton AG, Croft JB. Prevalence of Inflammatory Bowel Disease Among Adults Aged ≥18 Years – United States, 2015. MMWR Morb Mortal Wkly Rep. 2016;65(42):1166-1169. Published 2016 Oct 28. doi: 10.15585/mmwr. mm6542a3.

Ofitsialnyi sait Biuro natsionalnoi statistiki Agentstva po strategicheskomu planirovaniiu i reformam Respubliki Kazakhstan o chislennosti izuchaemykh grupp naseleniia. [The official website of the Bureau of National Statistics of the Agency for Strategic Planning and Reforms of the Republic of Kazakhstan on the size of the studied population groups]. Available from: www.stat.gov.kz

Merkov AM, Polyakov LE. Sanitarnaya statistika [Sanitary statistics]. Leningrad, Medicine; 1974:384

Glanc S. Mediko-biologicheskaya statistika [Biomedical statistics]. Moscow, Practice; 1999: 460

Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007;448(7152):427-434. doi: 10.1038/nature06005.

Juliao-Baños F, Kock J, Arrubla M, et al. Trends in the epidemiology of inflammatory bowel disease in Colombia by demographics and region using a nationally representative claims database and characterization of inflammatory bowel disease phenotype in a case series of Colombian patients. Medicine (Baltimore). 2021;100(7):e24729. doi: 10.1097/MD.0000000000024729.

Leddin D, Tamim H, Levy AR. Decreasing incidence of inflammatory bowel disease in eastern Canada: a population database study. BMC Gastroenterol. 2014;14:140. doi: 10.1186/1471-230X-14-140.

Laass MW, Roggenbuck D, Conrad K. Diagnosis and classification of Crohn's disease. Autoimmun Rev. 2014;13(4-5):467-471. doi: 10.1016/j.autrev.2014.01.029

Park J, Cheon JH. Incidence and Prevalence of Inflammatory Bowel Disease across Asia. Yonsei Med J. 2021;62(2):99-108. doi:10.3349/ymj.2021.62.2.99

##submission.downloads##

##submissions.published##

2020-12-07

##issue.issue##

##section.section##

Articles

##plugins.generic.recommendByAuthor.heading##